Anticoagulants after Myocardial Infarction

Use of anticoagulants in acute myocardial infarction.

T HE SCIENTIFIC BASIS for the use of anticoagulants in the treatment of acute myocardial infarction was established by Solandt, Nassim, and Best' in 1939. They produced mural thrombi in the hearts of dogs by injecting sodium ricinoleate into the myocardium after tying off a branch of the left coronary artery. Thrombus formation could be prevented by the injection of heparin intravenously. The a...

Self Care Behaviors in Patients after Myocardial Infarction

Introduction: One of determining and effective factors in health maintenance and prevention of progression of signs and symptoms of disease after heart attack is self care behaviors. The self care behaviors which can start after passing the acute period of disease has special importance in health maintanance and its recurrence. Objective: The aim of this study was to determine self care beha...

SERUM IgE AND BETA 2 MICROGLOBULIN LEVELS AFTER MYOCARDIAL INFARCTION

Serum IgE and beta 2 microglobulin levels were determined in 31 patients suffering from acute myocardial infarction and 30 patients with other forms of ischemic heart disease. The levels of these parameters were studied on the first, third and seventh day after the onset of disease. The immunological method used for the determinations was ELISA Patients with myocardial infarction showed an...

Anticoagulants for secondary prevention after acute myocardial infarction: lessons from the past decade

The impact of an acute coronary syndrome (ACS) event, such as an acute myocardial infarction (MI), is not limited to the acute management phase; patients face an elevated risk of residual atherothrombotic events that commonly requires chronic management for months or even years. Significant advances have been made in both the acute and chronic management of patients with acute MI over the past ...

Anticoagulants In The Treatment Of Myocardial Infarction — A Review